Exploration of tumour-infiltrating lymphocytes as a predictive biomarker for adjuvant endocrine therapy in early breast cancer

Author(s):
Blok, E.J.; Engels, C.C.; Dekker-Ensink, G.; Kranenbarg, E.M.K.; Putter, H.; Smit, V.T.H.B.M. (0000-0003-3730-5652); Liefers, G.J.; Morden, J.P.; Bliss, J.M.; Coombes, R.C.; Bartlett, J.M.S.; Kroep, J.R.; Velde, C.J.H. van de (0000-0003-0104-1800); Kuppen, P.J.K. (0000-0002-0294-3251)
Published
2018
Publication type
Article / Letter to editor
Breast cancerTumor infiltrating lymphocytesEndocrine therapyExemestaneTamoxifen
Date issued
2018-08-31
Language
English
Is part of
Breast Cancer Research and Treatment (2018), Vol. 171, no. 1, p. 65-74
hdl
1887/75205
doi
10.1007/s10549-018-4785-z
URL
https://link.springer.com/content/pdf/10.1007/s10549-018-4785-z.pdf